Isabelle Fournier and her team are out to change surgical oncology.
“Better surgery is associated with better prognosis and higher survival,” said Fournier, a professor at the University of Lille and co-director of a proteomics center of INSERM, the French national institute of health. Her laboratory has worked for several years on a device they call the SpiderMass that will enable surgeons to look for markers of cancer in a living patient’s tissue, during an operation. In an article in Molecular & Cellular Proteomics, the team reports on an important step toward finding protein biomarkers during surgery.
Surgery to remove a primary tumor involves a wait. After the tumor and some healthy surrounding tissue are removed, the surgical team pauses while a pathologist checks the tissue margins under a microscope. Although this process is important for preventing recurrence of the cancer, it can add up to 45 risky minutes under anesthesia.
With the new device, Fournier said, “We think that it is possible to open the way to in vivo real-time proteomics,” which could help surgeons find stray cancer cells faster, perhaps even as they make incisions.
Fournier’s device uses mass spectrometry, which measures the mass of molecules from complex mixtures. But turning an in vivo tissue sample into gas phase ions for measurements can be a challenge. Until now, no one knew how to extract ions from living tissues without doing harm.
So Fournier’s team got creative. Riffing on MALDI, an ionization strategy that uses a carrier molecule mixed with the analyte of interest, they decided to use the water that makes up a majority of human tissue as a carrier to produce a water-assisted laser desorption/ionization, or WALDI. If they could excite the water in a tiny area, it should vaporize, taking ionized organic molecules with it.
“It was an idea at the beginning, and many people thought that it would not work,” Fourier said. “Finally, we have it working beautifully.”
The team built a pulsed laser excitation device tuned to heat water precisely by causing vibration in the oxygen-hydrogen bond. In a 2016 paper, they described using this laser to ionize the outermost layer of tissue, penetrating less than one-twentieth of a millimeter. The human volunteers reported a slight tingling sensation. But the ions that appeared were mostly small molecules and lipids, which are more apt than proteins to adopt a negative charge. The team hoped to measure proteins as well.
In this new paper, Fournier and colleagues report that they have cracked the protein puzzle. By using a more sensitive mass spectrometer and looking for positively instead of negatively charged ions, they found peaks representing purified proteins they had introduced into a cow liver sample. Now that they know the proteins are detectable, the next step will be finding ways to amplify the protein signal over more abundant lipids and metabolites.
In the meantime, the device is already in use for four-legged patients. Fournier’s lab has worked with the veterinary biotech company Oncovet Clinical Research to run a pilot trial, comparing biopsies from pet dogs with sarcoma to healthy tissues. The team developed a lipidomics- and metabolomics-based classification system to robustly identify healthy, necrotic and cancerous tissues. Soon, they will introduce a prototype into a veterinary operating room. If it is successful there, Fournier said, she hopes to reach human clinics, improving tumor removal surgery to give patients better health outcomes.
The Latest on: Proteomics
via Google News
The Latest on: Proteomics
- Bioinformatics Market is Recurring & Impressive Growth in Helathcare Sector with CAGR of 13.8% from 2018 to 2025 on April 18, 2019 at 2:02 am
The growth of the global bioinformatics market is driven by the surge in need for integrated data, rise in growth in proteomics & genomics, and rapid drug discovery & development. However, dearth of ... […]
- Scientific Instruments Industry Outlook: Prospects Look Bright on April 17, 2019 at 6:14 pm
Additionally, pharma companies are focusing on rapidly growing areas like proteomics and phenomics, biopharma and applied, microbiology and diagnostics, and neuroscience and cell microscopy ... […]
- Proteomics Market Industry Research Report, Growth, Forecast and Competitive Analysis 2016-2026: FMI Research Report on April 16, 2019 at 8:36 pm
Valley Cottage, NY -- (SBWIRE) -- 04/16/2019 -- Proteome is an entire set of proteins which is produced by a system or an organism. It can vary with different time, requirements, stresses, that an ... […]
- The global proteomics is estimated to grow from $XX billion in 2018 to $58.3 billion by 2027, at a CAGR of 14.68% between 2019 and 2027 on April 16, 2019 at 3:24 pm
NEW YORK, April 16, 2019 /PRNewswire/ -- KEY FINDINGS Proteomics is the large scale study of overall protein content in any biological system.It involves the applications of technologies for the ... […]
- Proteomics Industry Global Market Analysis By Size, Share, Growth, Research By Top Companies and Forecast During 2019-2023 on April 16, 2019 at 12:43 pm
Apr 16, 2019 (AB Digital via COMTEX) -- The Global Proteomics Market is rising pervasively mainly due to the proliferating trend of personalized medicines. Proteomics is used in drug discovery and ... […]
- Thermo Fisher Scientific Announces Collaboration to Advance Noninvasive Risk Assessments of Pregnancy Outcomes on April 16, 2019 at 5:00 am
"The co-development of a commercially available clinical mass spectrometry-based proteomics assay has the potential to provide a diagnostic solution to both clinical scientists and medical ... […]
- Do Insiders Own Lots Of Shares In Proteomics International Laboratories Ltd (ASX:PIQ)? on April 15, 2019 at 5:41 pm
The big shareholder groups in Proteomics International Laboratories Ltd (ASX:PIQ) have power over the company. Insiders often own a large chunk of younger, smaller, companies while huge companies ... […]
- A photocleavable surfactant for top-down proteomics on April 15, 2019 at 8:09 am
We report the identification of a photocleavable anionic surfactant, 4-hexylphenylazosulfonate (Azo), which can be rapidly degraded by ultraviolet irradiation, for top-down proteomics. Azo can ... […]
- A comprehensive proteomics-based interaction screen that links DYRK1A to RNF169 and to the DNA damage response on April 12, 2019 at 2:09 am
Dysregulation of the DYRK1A protein kinase has been associated with human disease. On the one hand, its overexpression in trisomy 21 has been linked to certain pathological traits of Down syndrome, ... […]
via Bing News